Results 71 to 80 of about 68,822 (222)

What happens after an oral ingestion of haloperidol decanoate? – A case report

Jornal Brasileiro de Psiquiatria, 2019
Haloperidol decanoate is a first generation antipsychotic drug used to treat patients with schizophrenic disorder who require prolonged parenteral antipsychotic therapy.
João Perestrelo, Ana Coutinho, Georgina Lapa   +2 more
doaj   +1 more source

Symptomatic treatment of children with anti-NMDAR encephalitis. [PDF]

, 2016
AIM: We performed the first study on the perceived benefit and adverse effects of symptomatic management in children with anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis.
Brilot, F, Dale, R. C., Hong, M, Jones, H, Mohammad, Ss, Nosadini, M, Pillai, Sc, Sharpe, C   +7 more
core   +1 more source

Systemic medications associate with surgically treated cataract among adults over 50 years in Finland

Acta Ophthalmologica, EarlyView.
Abstract Purpose To identify associations between systemic drugs and cataract surgery in Finland. Methods A historic cohort study based on administrative data. Endpoint event was cataract surgery. Use of drugs in question was based on redeemed prescriptions and consisted of 156 drugs.
Antti Riikonen, Jari Haukka, Tuomas Lilius, Sirpa Loukovaara   +3 more
wiley   +1 more source

The effect of the anticholinergic burden on duration and severity of delirium in older hip‐surgery patients with and without haloperidol prophylaxis: A post hoc analysis

Brain and Behavior, 2021
Background Anticholinergic acting drugs have been associated with delirium in older patients. Objective To examine the association between the anticholinergic burden (ACB) and the duration and severity of delirium in older hip‐surgery patients with or ...
Monique P. H. Tillemans, Madelon H. Butterhoff‐Terlingen, Rutger Stuffken, Ralph Vreeswijk, Toine C. G. Egberts, Kees J. Kalisvaart   +5 more
doaj   +1 more source

IL-8 produced by T cells is under the control of dopamine signaling [PDF]

, 2018
学位記番号 ...
Matsuyama, Toshiyuki, マツヤマ, トシユキ, 松山, 敏之   +2 more
core  

Huntington's Disease‐like Syndrome as a Rare Presentation of CACNA1A‐Related Disorder

Movement Disorders Clinical Practice, EarlyView.
Petros Boumis, Constantin Potagas, Christos Koros, Vasilios Constantinides, Nikolaos Ragazos, Chrysoula Koniari, Stavroula Aristeidou, Chrisoula Kartanou, Emmanouela Linardaki, Nektarios Tavernarakis, Evangelos Anagnostou, Leonidas Stefanis, Socratis Papageorgiou, Georgia Karadima, Georgios Koutsis   +14 more
wiley   +1 more source

The Recruitment and Retention of Individuals With Intellectual Disability in Randomized Controlled Trials: A Scoping Review

British Journal of Learning Disabilities, EarlyView.
ABSTRACT Background People with intellectual disabilities face significant health disparities and often encounter barriers in accessing healthcare services. Although research supports the need for reasonable adjustments to improve healthcare access for this population, implementation in acute healthcare settings remains limited.
Owen Doody, Louise Murphy, Ruth Ryan, Rosemary Lyons, Wenyi Tang, Lorna Bourke   +5 more
wiley   +1 more source

Intravenous Haloperidol versus Midazolam in Management of Conversion Disorder; a Randomized Clinical Trial

Archives of Academic Emergency Medicine, 2018
Introduction: Conversion disorder is a condition in which the patient shows psychological stress in physical ways. This study aimed to compare the effects of haloperidol versus midazolam in patients with conversion disorder. Methods: This double-blind
Mohammadali Jafari, Amir Aliheidari Biuki, Majid Hajimaghsoudi, Mehdi Bagherabadi, Ehsan Zarepur   +4 more
doaj   +3 more sources

Acute transaminitis after initial days of starting haloperidol. [PDF]

, 2019
Haloperidol is a first-generation antipsychotic butyrophenone that is lipophilic, readily absorbed, and extensively metabolized in the liver. The occurrence of elevated liver enzymes with haloperidol is reported to be 2.4% with cases generally occurring ...
Bota, Robert, Farokhpay, Reza, Gabriel, Rami, Wojtanowicz, Todd   +3 more
core   +1 more source

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

British Journal of Pharmacology, EarlyView.
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander, Dasha Anderson, Luke Baxter, Matthew Claydon, James Rucker, Emma S. J. Robinson   +5 more
wiley   +1 more source